What factors determine patient adherence to osteoporosis treatment regimens?

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 2, 2007, Pages 80-81

  Rizzoli, René ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; CLODRONIC ACID; RALOXIFENE; VITAMIN D;

BONE DENSITY; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; NOTE; OSTEOPOROSIS; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; ULTRASOUND; UNSPECIFIED SIDE EFFECT;

EID: 33846407575     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0371     Document Type: Note

References (4)

1. Kanis JA et al. (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11: 669-674
2. Delmas PD et al. (2005) Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporos Int 16: 1-5
3. Caro JJ et al. (2004) The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 15: 1003-1008
4. Cramer JA et al. (2005) Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 21: 1453-1460